Alexion Spikes As Company Hires Goldman Sachs (ALXN)
Shares of Alexion jumped as high as $120.48, or 10.2 percent on the news. More than 2.5 million shares have already been traded, compared to the average of 2.03 million.
A previous offer from Roche was rejected, but Alexion will be working with Goldman Sachs in the case that Roche raises their offer to a level the pharmaceutical company finds appealing.
Bloomberg reported that Roche is interested in both the company’s blood medication and pipeline.
Analysts will likely review the company in the near future.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.